Search
for
Sort by
Research 61–90 of 610
- Progressive Zinc and Iron Deficiency Following Bariatric Surgery in Iraqi Patients: A 12-Month Pilot Study
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Obesity and polycystic ovary syndrome
- The role of diet in the management of psoriasis: a scoping review
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Holistic approaches to PCOS: Diet, Exercise and Mental well-being.
- Androgen-Related Alopecia and Infertility: Impact of Lifestyle Modifications
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- The Rotterdam Study: 2016 objectives and design update
- What causes hidradenitis suppurativa ?—15 years after
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Sleep disturbances in women with polycystic ovary syndrome
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Integrated Model of Care for Polycystic Ovary Syndrome
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- PCOS and Obesity: Contraception Challenges
- Metabolic Syndrome and Skin Disease: Potential Connection and Risk
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Debatable Topics in PCOS Patients
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students